While this coincides with an uptick in GLP-1 drug use, some experts told Newsweek they don't think they are having a major ...

() - The number of states with the highest obesity rates declined in 2024, while Nevada’s obesity epidemic deepened. Last ...

A new deal between the White House and pharmaceutical companies like Novo Nordisk and Eli Lilly is shaking things up.

President Donald Trump announced major GLP-1 drug price cuts with Eli Lilly and Novo Nordisk, reducing costs for Ozempic and Wegovy.

U.S. Senator Says President Trump is Appealing a Court Order to Give Hungry People Money to Feed Their Families While Sending $40 Billion to Argentina and Spending $300 Million to Remodel the White ...

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to reduce prices for their obesity ...

MAHA advocates are skeptical of President Donald Trump's deal to lower drug prices for GLP-1 anti-obesity drugs.

Novo Nordisk (($NVO)) has held its Q3 earnings call. Read on for the main highlights of the call. Novo Nordisk’s recent earnings call presented a ...

Trump secures a major deal with Eli Lilly and Novo Nordisk to cut obesity drug costs as Medicare expands coverage for ...

The Trump administration plans to unveil new dietary guidelines in December aimed at tackling the obesity epidemic and altering the American food culture, according to U.S. Health Secretary Robert F.

WASHINGTON -- Part of America's obesity problem comes from people not recognizing how precious their own lives are, Mehmet Oz, MD, MBA, administrator of CMS, said on Monday. "Most people that I talk ...

The article delves into the rising global prevalence of obesity and the multifaceted challenges of addressing it. Though new ...